A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines (Q39373123)

11 September 2017

title

A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines (English)

1 reference

11 September 2017

1 reference

Million A Tegenge

1

1 reference

11 September 2017

Robert J Mitkus

series ordinal

2

1 reference

11 September 2017

publication date

4 August 2013

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

11 September 2017

published in

1 reference

11 September 2017

volume

40

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

545-556

1 reference

Immunological mechanisms of vaccination

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Beyond empiricism: informing vaccine development through innate immunity research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Reverse Vaccinology: Developing Vaccines in the Era of Genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Aflunov(®): a prepandemic influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

MF59 adjuvant: the best insurance against influenza strain diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

The mechanism of action of MF59 - an innately attractive adjuvant formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

A global regulatory science agenda for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Overview of global regulatory toxicology requirements for vaccines and adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Nonclinical safety assessment of vaccines and adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Postabsorptive metabolism of dietary squalene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Squalene emulsions for parenteral vaccine and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Effects of a TV drama series upon public impressions about psychiatrists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Metabolic Fate of Mineral Oil Adjuvants Using 14C-Labeled Tracers II: Mannide Monooleate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Squalene-based oil-in-water emulsion adjuvants perturb metabolism of neutral lipids and enhance lipid droplet formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Loss of IL-15 receptor α alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

The physiology of the lymphatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Physiological parameter values for physiologically based pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Blood flow in muscle groups and drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Quantitative Analysis of the Deltoid and Rotator Cuff Muscles in Humans and Great Apes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Synthesis of fatty acids and cholesterol by liver, adipose tissue and intestinal mucosa from obese and control patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

MF59™ as a vaccine adjuvant: a review of safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Safety review: squalene and thimerosal in vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

21 January 2018

Safety of MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Molecular and cellular signatures of human vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Dendritic cells internalize vaccine adjuvant after intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9328-Y

Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice

21 January 2018

1 reference

12 December 2020

In vivo studies of sterol and squalene secretion by human skin.

1 reference

12 December 2020

The Site of Sterol and Squalene Synthesis in the Human Skin123

1 reference

12 December 2020

Measurement of squalene in human tissues and plasma: validation and application

1 reference

12 December 2020

Metabolism of squalene in human fat cells. Demonstration of a two-pool system

1 reference

12 December 2020

Absorption and metabolic fate of dietary 3H-squalene in the rat

1 reference

12 December 2020

Fate of intravenously administered squalene and plant sterols in human subjects

1 reference

12 December 2020

Dietary obesity in nine inbred mouse strains

1 reference

12 December 2020

Transport of macromolecules across microvascular walls: the two-pore theory

1 reference

12 December 2020

Fate of intravenously administered squalene in the rat

1 reference

12 December 2020

Cholesterol synthesis and storage in adipose tissue

1 reference

12 December 2020

MF59. Design and evaluation of a safe and potent adjuvant for human vaccines

1 reference

12 December 2020

Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method

1 reference

12 December 2020

Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.

1 reference

12 December 2020

Determination of deltoid fat pad thickness. Implications for needle length in adult immunization

1 reference

12 December 2020

MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action

1 reference

12 December 2020

10.1007/S10928-013-9328-Y

Identifiers

DOI

1 reference

11 September 2017

1 reference